ResMed (NYSE: RMD) net income
ResMed reported a net profit of $1,523m for fiscal 2026, 8.8% more than in fiscal 2025 ($1,401m). Its net margin was 26.9%. Earnings per share were $10.47.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2026 | $1,523m | +8.8% | 26.9% | $10.47 |
| 2025 | $1,401m | +37.2% | 27.2% | $9.55 |
| 2024 | $1,021m | +13.7% | 21.8% | $6.94 |
| 2023 | $897.6m | +15.2% | 21.3% | $6.12 |
| 2022 | $779.4m | +64.3% | 21.8% | $5.34 |
| 2021 | $474.5m | −23.7% | 14.8% | $3.27 |
| 2020 | $621.7m | +53.7% | 21.0% | $4.31 |
| 2019 | $404.6m | +28.2% | 15.5% | $2.83 |
| 2018 | $315.6m | −7.8% | 13.5% | $2.21 |
| 2017 | $342.3m | — | 16.6% | $2.42 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the net income of ResMed
- How much did ResMed earn in fiscal 2026?
- ResMed reported a net profit of $1,523m for fiscal 2026. In fiscal 2025 it reported a net profit of $1,401m.
- What are the earnings per share of ResMed?
- They were $10.47 in fiscal 2026, compared with $9.55 in fiscal 2025.
- What is the net margin of ResMed?
- In fiscal 2026 its net profit was 26.9% of its revenue.
- What was the most profitable year for ResMed?
- Of its last 10 fiscal years, fiscal 2026, with $1,523m.
- Where do the figures for ResMed come from?
- From the annual report (Form 10-K) that ResMed files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that ResMed files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on ResMed: the ResMed page · annual accounts · revenue · dividends paid · insider transactions.
Dividend per share of ResMed by fiscal year, with the filing behind every figure: ResMed dividend history.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.